The Impact of Malnutrition on Immune Responses to Tuberculosis
NCT ID: NCT05044910
Last Updated: 2024-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2020-08-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tuberculosis - Learning the Impact of Nutrition
NCT03598842
Comorbidities and Coinfections in Latent TB
NCT04642755
Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)
NCT04972903
Nutrition, Immunology and Epidemiology of Tuberculosis
NCT00197704
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAM children with TB disease
Ready to Use supplementary food (RUSF)
Children with malnutrition will be given RUSF
Wellnourished children with TB disease
No interventions assigned to this group
MAM children with latent TB infection
Ready to Use supplementary food (RUSF)
Children with malnutrition will be given RUSF
Well-nourished children with latent TB infection
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ready to Use supplementary food (RUSF)
Children with malnutrition will be given RUSF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV-negative
* BCG vaccinated
* Moderate acute malnutrition (WHZ -2 to -3 or MUAC 115 - 125mm ± HAZ \<-2)
* TB disease
* Latent TB infection
* Severe acute malnutrition (WHZ\<-3; MUAC\<115mm; bilateral oedema)
* Severe anaemia (Hb: \<7g/dl)
* Chronic infection (HIV, hepatitis B or C)
* Chronic disease (e.g. Crohn's disease)
* Feeding problems (eg cerebral palsy) that prevent ingestion of RUSF
* Known nut allergy
* MDR TB disease and contacts of MDR TB adults
12 Months
60 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Child Health, Madras Medical College, Chennai
UNKNOWN
Stanley Medical College
OTHER_GOV
Kanchi Kamakoti Childs Trust Hospital, Chennai, India
UNKNOWN
Queen Mary University of London
OTHER
London School of Hygiene and Tropical Medicine
OTHER
DBT, India
UNKNOWN
Tuberculosis Research Centre, India
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aishwarya Venkataraman, MRCPCH
Role: PRINCIPAL_INVESTIGATOR
ICMR-NIRT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Child Health
Chennai, Tamil Nadu, India
Government Stanley Medical College and Hospital
Chennai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Venkataraman A, Shanmugam S, Balaji S, Mani K, Shanmugavel AK, Muthuramalingam K, Hissar S, Thiruvengadam K, Selladurai E, Smuk M, Hanna LE, Prendergast AJ. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children. Tuberculosis (Edinb). 2022 Dec;137:102255. doi: 10.1016/j.tube.2022.102255. Epub 2022 Aug 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.